Mesenchymal stem cell therapy as adjunctive treatment in pediatric patients with severe acquired brain injury: a single-center retrospective case series - Top-Institutions - MDSpire

Mesenchymal stem cell therapy as adjunctive treatment in pediatric patients with severe acquired brain injury: a single-center retrospective case series

  • By

  • Hacer Uçmak

  • Merve Havan

  • Anar Gurbanov

  • Burak Balaban

  • Fevzi Kahveci

  • Hasan Özen

  • Edin Botan

  • Emrah Gün

  • Ayşen Durak Aslan

  • Eda Eyduran

  • Ömer Bektaş

  • Ayşe Eser Elçin

  • Tanıl Kendirli

  • July 14, 2026

Share

Top Institutions in Pediatrics

Brief introduction explaining scope and methodology.

  • #1

    Ankara University Faculty of Medicine
    Ankara University Faculty of Medicine

    Ankara, Turkey

    Key Differentiators

    • Pediatrics

  • #2

    pediatric intensive care unit
    pediatric intensive care unit

    Unknown, Unknown

    Key Differentiators

    • Pediatrics

  • #3

    Bambino Gesù Children’s Hospital
    Bambino Gesù Children’s Hospital

    Rome, Italy

    Key Differentiators

    • Pediatrics

Original Source(s)

Mesenchymal stem cell therapy as adjunctive treatment in pediatric patients with severe acquired brain injury: a single-center retrospective case series

  • by Hacer Uçmak, Merve Havan, Anar Gurbanov, Burak Balaban, Fevzi Kahveci, Hasan Özen, Edin Botan, Emrah Gün, Ayşen Durak Aslan, Eda Eyduran, Ömer Bektaş, Ayşe Eser Elçin, Tanıl Kendirli

  • July 14, 2026

Related Content

Errors in Table 3

  • July 9, 2026

Digital technologies for non-invasive stress detection, monitoring, and mitigation in children and adolescents: a scoping review

Postoperative remodeling and developmental improvement of femoral trochlear dysplasia in pediatric habitual patellar dislocation